CapForce Inc.
CFOR- Exchange
- OTC
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001293818
No open-market purchases or sales by CapForce Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding CapForce Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 13 | 7 | −6 |
| Shares | 464.5K | 4.76K | −459.7K (−99.0%) |
| Value | $322.1K | $12.3K | −$309.8K (−96.2%) |
New holders (0)
Institutions that held CapForce Inc. at the end of Q2 2024 but not at the end of Q1 2024.
None.
Sold out (6)
Institutions that held CapForce Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Chase Investment Counsel Corp | 331,890 | $230.0K |
| Vanguard Group Inc | 53,275 | $37.0K |
| Geode Capital Management, LLC | 36,301 | $25.2K |
| Boston Private Wealth LLC | 18,219 | $12.7K |
| Wells Fargo & Company | 78 | $54 |
| BNP Paribas | 1 | $0 |